细胞免疫疗法和免疫细胞生物标志物的成像：从临床前研究到患者

Cellular immunotherapies have emerged as a successful therapeutic approach to fight a wide range of human diseases, including cancer.

However, responses are limited to few patients and tumor types. An in-depth understanding of the complexity and dynamics of cellular immunotherapeutics, including what is behind their success and failure in a patient, the role of other immune cell types and molecular biomarkers in determining a response, is now paramount. As the cellular immunotherapy arsenal expands, whole-body non-invasive molecular imaging can shed a light on their in vivo fate and contribute to the reliable assessment of treatment outcome and prediction of therapeutic response.

In this review, we outline the non-invasive strategies that can be tailored toward the molecular imaging of cellular immunotherapies and immune-related components, with a focus on those that have been extensively tested preclinically and are currently under clinical development or have already entered the clinical trial phase.

We also provide a critical appraisal on the current role and consolidation of molecular imaging into clinical practice.